Bayesian Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,800
Closed -$66.4K 833
2024
Q4
$66.4K Buy
+16,800
New +$75.2K 0.01% 623
2024
Q1
Sell
-22,000
Closed -$108K 992
2023
Q4
$108K Sell
22,000
-39,000
-64% -$191K 0.01% 652
2023
Q3
$332K Sell
61,000
-29,900
-33% -$240K 0.04% 451
2023
Q2
$842K Buy
90,900
+55,100
+154% +$466K 0.09% 298
2023
Q1
$294K Buy
35,800
+3,700
+12% +$40.9K 0.04% 512
2022
Q4
$358K Buy
+32,100
New +$373K 0.05% 439
2022
Q2
Sell
-25,000
Closed -$528K 968
2022
Q1
$528K Buy
+25,000
New +$539K 0.08% 358
2021
Q3
Sell
-19,600
Closed -$394K 482
2021
Q2
$394K Buy
+19,600
New +$419K 0.1% 221
2020
Q2
Sell
-21,271
Closed -$368K 678
2020
Q1
$368K Buy
+21,271
New +$445K 0.08% 381

Other funds holding MPT

Bayesian Capital Management's MPT Position: Q1 2025 in Review

Bayesian Capital Management sold out of Medical Properties Trust (MPT) in Q1 2025, closing a stake of 16,800 shares — an estimated $66.4K sold.

Bayesian Capital Management first reported a position in MPT in Q1 2020 and held it in 9 quarters. The position peaked at $842K in Q2 2023. 470 funds tracked by Wall St. Rank hold MPT as of Q1 2025.

  • Bayesian Capital Management reported no remaining Medical Properties Trust position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 16,800 Medical Properties Trust shares in Q1 2025, an estimated $66.4K.
  • Bayesian Capital Management first reported a position in Medical Properties Trust in Q1 2020 and held it in 9 quarters.
  • Bayesian Capital Management's Medical Properties Trust position peaked at $842K in Q2 2023.
  • 470 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.